INSIGHTS ON DRUG DEVELOPMENT

• Targeted Modalities Set Elevated Standards For Precision

  Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.

• Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs)

  ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

• Enhance Cell Line Development With Rapid Whole-Well Imaging

  Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.

• The Top Tech Transfer Risks At Multi-Site CDMOs

  Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.

• Ask Us Anything: Cy Credille On Continuity From Discovery To Commercialization

  7/24/2026

  Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.

• EMA Support For SMEs Through Scientific Advice And Early Dialogue

  5/6/2026

  Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.

• Integration From Formulation Development To Manufacturing, Packaging

  2/27/2025

  Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

• Seed Train Intensification Using High Cell Density Cryopreservation

  8/11/2025

  Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.

• Development Of Scalable Purification For Biotherapeutic Peptides

  8/26/2025

  Discover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.